Actiq 400mcg OTFC Lozenges

Understanding Actiq (Fentanyl Citrate) 400mcg OTFC Lozenges: A Comprehensive Overview

Actiq 400mcg OTFC Lozenges, is a prescription medication containing fentanyl citrate, a potent synthetic opioid analgesic. Administer as an oral transmucosal lozenge (OTFC), it is specifically design to manage breakthrough pain in cancer patients who are already receiving and are tolerant to around-the-clock opioid therapy for their underlying persistent cancer pain.

---

What Is Actiq?

Actiq 400mcg OTFC Lozenges, is a lozenge attach to a handle, resembling a lollipop, containing fentanyl citrate. When place in the mouth, it dissolves slowly, allowing the medication to be absorb through the oral mucosa directly into the bloodstream. This method enables rapid onset of pain relief, typically within 15 minutes.

---

Indications and Usage

Actiq is indicate for the management of breakthrough pain in cancer patients age 16 years and older who are already receiving and are tolerant to around-the-clock opioid therapy for their underlying persistent cancer pain. Patients consider opioid-tolerant are those who have been taking, for one week or longer, around-the-clock medicine consisting of at least:

• 60 mg of oral morphine per day

• 25 mcg of transdermal fentanyl per hour

• 30 mg of oral oxycodone per day

• 8 mg of oral hydromorphone per day

• 25 mg of oral oxymorphone per day

• 60 mg of oral hydrocodone per day

• An equianalgesic dose of another opioid

Patients must remain on around-the-clock opioids while taking Actiq.

---

Contraindications and Warnings

Actiq is contraindicate in:

• Opioid non-tolerant patients.

• Management of acute or postoperative pain, including headache/migraine and dental pain.

• Intolerance or hypersensitivity to fentanyl or components of Actiq.

Life-threatening respiratory depression and death can occur if use improperly. Patients and their caregivers must be instructed that children expose to Actiq are at high risk of fatal respiratory depression. Unused or partially consumed units must be properly dispose of immediately.

---

Pharmacology and Mechanism of Action

Fentanyl, the active ingredient in Actiq, is a synthetic opioid that acts on the mu-receptors in the brain and spinal cord to produce analgesia. It is estimated to be 50 to 100 times more potent than morphine. The oral transmucosal formulation allows for rapid absorption, providing quick relief for breakthrough pain episodes.

---

Important Safety Information

• Administration: Actiq should be used only by patients who are opioid-tolerant.

• Dosage: The 400 mcg strength is one of several available dosages.

• Storage: Keep out of reach of children.

• Disposal: Unused or partially consumed units must be properly disposed of immediately.

Actiq (fentanyl citrate) 400mcg OTFC lozenges offer a rapid and effective solution for managing breakthrough cancer pain in opioid-tolerant patients. However, due to the risks associated with opioid use, it is essential that Actiq is prescribed and used under strict medical supervision, adhering to all safety guidelines to minimize potential risks.